Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-29 @ 12:45 AM
Study NCT ID:
NCT06091956
Status:
COMPLETED
Last Update Posted:
2025-06-08
First Post:
2023-10-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Deucravacitinib to Treat LPP and FFA
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
Deucravacitinib (BMS-986165) in the Treatment of Lichen Planopilaris
Status:
COMPLETED
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: